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Abstract 
BACKGROUND: 
Adolescents, aged 12-19 years, represent the fastest growing segment of the 
population affected by the obesity (overweight) epidemic. A simultaneous and 
equally important trend in the United States (U.S.) is the increasing prevalence of 
children and adolescents with type 2 diabetes mellitus (DM). Although type 2 
DM is an obesity-related disease in adults, a causal relationship between 
adolescent overweight and pediatric type 2 DM is suspected but not established. 
OBJECTIVES: 
The main objective of this review is to systematically explore the association 
between overweight and type 2 DM in adolescents, and consider the magnitude of 
any identified association. The principal question is: Within the U.S. adolescent 
population aged 12-19 years old, is overweight- defined as Body Mass Index 
(BMl) -for-age 2: 95th percentile (with 85th to <95th percentile considered at risk 
for overweight)- associated with the development of type 2 diabetes mellitus 
during adolescence? 
METHODS: 
Search Strategy- I obtained studies through systematic electronic database 
searches ofMedline via PubMed and the Cochrane library, supplemented by a 
manual search of selected journals and bibliographies. Selection criteria-
Original research articles published in English, involving the U.S. adolescent 
population, and addressing overweight and/or type 2 DM were eligible for 
inclusion. Data collection & analysis: The primary author independently 
reviewed relevant studies and extracted evidence into tabular format for analysis. 
MAIN RESULTS: 
Eight studies were relevant to the key question (or its pre-defined subcomponent) 
and rated as fair or good quality. Study designs were prospective longitudinal, 
cross-sectional, and retrospective cohort, and sample sizes ranged from 36 to 
1,242. Outcome measures included BMl, type 2 DM, impaired glucose tolerance, 
and hyperinsulinism. All studies had flaws, including small sample size, general 
methodological inconsistencies, and compromised internal validity. 
CONCLUSIONS: 
Overall, the body of evidence identified for this review concentrates on an 
association between overweight and metabolic disturbances related to type 2 DM, 
rather than on type 2 DM specifically. Insufficient evidence is available to 
reliably conclude on a causal association between overweight status and 
development of type 2 DM in adolescence. The magnitude of results identified by 
this review is strong enough to suggest such an association; however, there is a 
need for research defining true metabolic precursors of adolescent-onset type 2 
DM. 
iii 
Preface & Definitions 
Overweight vs. Obesity 
Some authors use the terms obese and overweight interchangeably in 
regards to the pediatric population. Others define overweight in the range of 
851h -951h percentile body mass index-for-age (BMI-for-age) aod reserve the 
term obesity for those at greater thao the 951h percentile. The latter parameters 
are based appropriately on the 2000 Centers for Disease Control and 
Prevention (CDC) BMI-for-age growth charts, but use nomenclature common 
to adults. These multiple definitions provide inconsistencies in educating 
patients aod further difficulty in keeping current, stable information among 
practitioners.1 
As of 2000, the pediatric criteria used by the CDC designate overweight as 
::':951h percentile BMI for age; while a BMI between the 851h and 951h 
percentile is considered being at risk for overweight2 This paper relies on the 
CDC definitions and focuses on those individuals in the overweight category. 
[Note: the title page uses the term obesity in reference to the adolescent 
obesity epidemic in its global sense]. 
Definition of Adolescent: 
The defining age limits for the adolescent population vary depending on 
the resource used; the lower limit raoges from 12 to 13 years of age, and the 
upper limit from 18 to 19 years of age. For the purposes of this discussion, I 
will define adolescents as individuals whose age raoges from 12 to 19 years 
old. This definition allows the broadest literature inclusion and is also the 
1 
grouping used by the United States Preventive Services Task Force (USPSTF) 
and the National Health and Nutrition Examination Survey (NHANES). 
Nomenclature of Diabetes: 
Diabetes mellitus (DM) consists of two traditionally recognized entities, 
type one and type two. Over the years, a number of synonymous terms have 
come to represent each form. For example, type one DM was originally 
termed insulin-dependent diabetes mellitus (IDDM), juvenile-onset, or written 
as type I using Roman numeral format. Similarly, type two DM was termed 
non-insulin dependent diabetes mellitus (NIDDM), adult-onset, and 
documented as type II. Although each of these expressions continues to be 
widely used in the literature, this paper distinguishes forms of diabetes by 
using the terminology type 1 DM or type 2 DM. 
This latter terminology is preferable for several reasons. First, the terms 
NIDDM and adult-onset are obsolete given that many so-designated patients 
actually require insulin injections and have not reached adulthood. Second, 
use of the Roman numeral format in written medical records can lead to 
clerical and interpretation errors. Finally, the numerical nomenclatures 
recognize etiology of disease rather than treatment outcomes. However, in 
direct quotes or in evidence tables, I use the referenced authors' preferred 
(documented) nomenclature rather than assuming he I she means type 1 or 
type 2. 
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Introduction 
Over the past several decades, the prevalence of childhood overweight has 
reached epidemic proportions in the US. Adolescents (aged 12-19years) 
represent the fastest growing segment of the population affected by this 
condition. The increased rate of adolescent overweight is concerning, 
particularly when compared to the remainder of the pediatric subset. The 
most recent data released by the National Health and Nutrition Examination 
Survey (NHANES) approximates that 16.1% of children aged 6-19 years meet 
the definition of overweight (BMI-for-age ::0: 95th percentile)3 While the 
percent of overweight children aged 6 to 11 years more than doubled (6.5% to 
15.3%) from the late 1970s to 2000, the percent of overweight adolescents 
actually tripled (5.0% to 15.3%) during those same decades4 
A simultaneous and equally important trend in the US is the increasing 
prevalence of children and adolescents with type 2 diabetes mellitus (DM). 
Although population-based data are not yet published, available statistics 
indicate a rising incidence rate. For example, in Cincinnati, the incidence of 
adolescent type 2 DM increased from 0.7/100,000 new cases per year in 1982 
to 7.2/100,000 in 19945 Overall, type2 DM represents 8% to 45% of all 
cases of diabetes currently diagnosed in pediatric centers. 6 
In spite of type 2 DM being an obesity-related disease in adults, a causal 
relationship between adolescent overweight and pediatric type 2 DM has not 
been established. According to one source, being overweight puts adolescents 
at greater than two times the risk of diabetes mellitus compared to non-
3 
overweight children. 7 One recent study of overweight youth found that 21% 
of the 112 adolescents studied had impaired glucose tolerance that placed 
them at high risk for developing type 2 diabetes8 
The potential association between overweight and type 2 DM in 
adolescents is a public health concern for a number of reasons. First, the rates 
of overweight and type 2 DM are not only rising within the entire population, 
but also affiicting children at increasingly younger ages6 ' 9 Second, although 
the direct adulthood consequences of pediatric overweight remain unclear, the 
best predictor of becoming an overweight adult is being an overweight 
adolescent. 10 According to Whitaker et al., 80% of children with BMls C':95th 
percentile become overweight adults. 1° Finally, type 2 DM in adolescents may 
represent a direct consequence of overweight which actually manifests prior to 
adulthood. The implications of such an association for policy change, 
targeted prevention, and health education are many. 
Consider, for example, how the changing demographics of type 2 DM 
may affect pediatric education and training. Many pediatric care providers are 
unaccustomed to seeing patients with type 2 DM because it was previously an 
adult-associated condition. Updating the knowledge of practitioners will 
require additional training at multiple levels, including medical I nursing 
schools, residency programs, and continuing medical education. Also, the 
medical community will require a set of standards for treatment and diagnosis 
specific to this population. A recent survey of health care providers, the 
majority of whom were pediatric endocrinologists, explored the perceived 
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obstacles to caring for adolescents with type 2 DM. 11 Seventy three percent of 
respondents listed a lack of evidence-based practice guidelines as one such 
barrier11 
This paper will systematically explore the association between overweight 
and type 2 DM in adolescents, and consider the magnitude of any identified 
association. 
Adolescent Overweight 
Burden of Suffering: 
Background 
The percentage of adolescents who are overweight has tripled from 1980-
2002, and an estimated 15-30% (9 million) of children and adolescents (aged 6-19 
years) are overweight. 12 According to the Centers for Disease Control and 
Prevention( CDC), overweight status puts youth at 10 times greater risk for 
hypertension, 3-8 times the risk for dyslipidemia, and greater than two times that 
of normal children for diabetes mellitus7 Other co-morbidities that increase with 
being overweight include asthma, pseudotumor cerebri, slipped capital femoral 
epiphysis, and cholelithiasis1, as well as depressed self-esteem and problematic 
social interaction. 12 
Risk Factors: 
The etiology of overweight is multicausal, and genetic factors are usually 
accepted as a component. Although ethnicity cannot be cited as a cause, 
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associations exist between increased weight and certain ethnic groups. Currently, 
Mexican-American boys and African-American girls have the highest prevalence 
among U.S. adolescents3 Also, a sedentary lifestyle is thought to contribute 
profoundly. According to the Department of Health and Human Services (2001), 
half of U.S. young adults (aged 12-21 years old) are not active on a regular basis; 
and approximately 14% report no physical activity at all. 
Other postulated risk factors include: low parental education, social deprivation, 
early puberty, gestational diabetes, and infant feeding patterns. 12 
Pediatric Type 2 Diabetes Mellitus 
Burden of Suffering: 
Previously recognized as a disease of adulthood, type 2 DM now occurs in 
younger and younger age groups. 13 Most of the current prevalence data comes 
from case reports in clinic populations, so the precise national incidence rate 
remains unknown. However, type 2 DM in youth is the most rapidly growing 
form of diabetes in the U. S. 14 The National Diabetes Education Program15 cites 
two clinic-based studies illustrating that the percentage of newly diagnosed 
diabetic children with type 2 DM has risen from <5% before 1994 to 30-50% in 
subsequent years. 16' 17 
Risk Factors: 
Although the term type 2 DM denotes a metabolic disorder characterized by 
insulin resistance, various degrees of beta-cell failure, insulin deficiency, and 
increased hepatic glucose output13• 18' 19, the exact determinants of type 2 DM in 
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young people are unknown. Also, some characteristics of youth-onset type 2 DM 
overlap with those of type 1 DM, making diagnosis more difficult. 
To further complicate the clinical picture, the onset and course of type 2 DM 
in the pediatric population is unpredictable. Authors disagree on the typical 
presentation. Libman, eta!., suggest that up to 50% of youth with type 2 DM are 
asymptomatic, and that diagnosis is often based on an incidental finding of 
glucosuria or hyperglycemia.20 In contrast, a study conducted by Lipton, eta!., 
suggest that the majority of young patients present with severe onset of signs and 
symptoms, regardless of type 1, type 2 or undetermined status. 21 . 
Review Question 
Despite ambiguity, one consistency is that youth with type 2 DM tend to be 
overweight. 13' 17 This systematic review seeks to answer the following key 
question: Within the U.S. adolescent population aged 12-19 years old, is 
overweight- defined as BMl-for-age 2: 95th percentile (with 85th to <95th 
percentile considered at risk for overweight) - associated with the development of 
type 2 diabetes mellitus during adolescence? A related subcomponent question 
is: Within the U.S. adolescent population, is overweight associated with the 
development of conventional precursors of type 2 diabetes mellitus during 
adolescence - namely insulin resistance or insensitivity, impaired glucose 
tolerance, or hyperinsulinism? 
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Methods 
For this systematic review, I consulted various sources for design and 
implementation22"26, but served as the primary investigator and author. 
Search strategy: 
Appendix B outlines the search strategy. To identify relevant literature, I 
obtained studies through electronic database searches ofMedline via PubMed and 
the Cochrane library. With the assistance of a medical librarian, I searched 
Medline using the following Medical Subject Headings (MeSH) terms and 
combinations: "Obesity"[MeSH] combined with "Adolescent"[MeSH] OR 
"Adolescent Health Services" [MeSH] OR "Adolescent Nutrition"[MeSH] OR 
"Adolescent Behavior" [MeSH] OR "Adolescent. (Repeating the search with 
"Obesity"[MeSH] limited to Adolescents yielded identical results). I then 
combined the preceding search history with "Diabetes Mellitus, Type 2" [MeSH]. 
The date of the Medline search was December 16th, 2006. I placed no limits on 
publication date such that the full extent ofPubMed entries (i.e. dated back to 
1966) was potentially available. I supplemented this electronic search with a 
manual search of selected journals and bibliographies. 
Study Selection: 
Tvoes of Studies: I included only original research, meaning no letters to 
the editor, non-systematic review articles, commentaries, or conference 
proceedings. Acceptable study designs were observational (cross-sectional, case-
control, or cohort), systematic reviews, or randomized controlled trials. All 
8 
eligible studies were published in English. I placed no limitations on study 
duration or sample size in order to capture an adequate number of publications. 
Twes of Participants: All study populations included, but were not limited 
to, the adolescent age group - 12 to 19 years old. Additionally, I required that the 
research deal with participants residing in the U.S. The reason for this latter 
criterion was to focus on the immediate population that American-based health 
care providers encounter. Also, the time and resource limitations of this review 
were not conducive to international query. 
Twes of Outcome Measures: Acceptable diagnostic criteria for 
overweight included BMI-for-age percentiles defined by the 2000 CDC growth 
charts; crude BMI; or the author's statement of diagnosis. Acceptable diagnostic 
criteria for diabetes included those defined by the American Diabetes Association 
(ADA 1997); the World Health Organization (WHO 1985); the National Diabetes 
Data Group standards (NDDG 1979); or the author's statement of diagnosis. 
Data extraction strategy: 
I independently reviewed eligible studies and extracted evidence into 
tabular format for analysis. 
Study quality assessment: 
I derived quality assessment criteria from a critical appraisal template 
developed for Health Care and Prevention at the University ofNorth Carolina at 
Chapel Hill (see Appendix A); and used example coding instructions for quality 
assessmene6 to adapt checklist questions. I assessed internal validity by 
examining potential selection bias, measurement bias, confounding, and attrition 
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rates. I assessed external validity based on each study's applicability to 
overweight adolescents in the U.S. This assessment was separate from, and had 
no influence on, determination of internal validity. 
In order to rate the overall quality of evidence, I relied on the Grades of 
Recommendation Assessment, Development and Evaluation (GRADE) Working 
Group approach. The GRADE working group describes quality of evidence as 
"the extent to which one can be confident that an estimate of effect is correct. "23 
Definitions of quality grade are as follows: High indicates that further research is 
very unlikely to change confidence in the estimate of effect; Moderate indicates 
that further research is likely to have an important impact on confidence in the 
estimate of effect and may change the estimate; Low indicates that further 
research is very likely to have an important 
impact on confidence in the estimate of effect and is likely to change the estimate; 
and Very Low indicates that any estimate of effect is very uncertain. 23 
Data synthesis approach: 
I used a non-quantitative data synthesis approach because the studies were 
too heterogeneous in nature to perform a quantitative analysis. Not only did 
studies differ in terms of results, but also in terms of participant characteristics 
and outcome measures (clinical heterogeneitl6) as well as study design 
(methodological heterogeneity26). I used recommendations outlined by the Centre 
for Reviews and Dissemination in order to complete a descriptive data synthesis. 26 
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Results 
Overview of included I excluded studies: 
Appendix C presents the flow of the literature in a quorum tree. In total, I 
found 423 citations potentially relevant to the research question. The electronic 
literature search ofMedline (via PubMed) yielded 403 citations, and I identified 
an additional20 pertinent citations through manual exploration of bibliographies 
from selected review articles and letters. I independently reviewed all titles and 
citations, liberally applied the pre-determined selection criteria (see Appendix D) 
to available abstracts, and then stringently reapplied the selection criteria (see 
Appendix E) to remaining full text articles. 
I excluded 394 citations, abstracts, and full text publications for the 
following reasons: 151 were not related to diabetes I obesity or had an 
inappropriate outcome; 103 were not original research; 98 did not involve United 
States participants; 29 did not encompass the adolescent population; 5 had the 
wrong study design; 4 were unavailable in full text; and 4 were not published in 
English. 
In all, I included 9 publications in the systematic review: 5 concurrent 
cross-sectional studies, 2 cross-sectional studies using retrospective chart review, 
and 2 prospective longitudinal cohort studies. For each study, I extracted data 
into evidence tables to grade quality. I subsequently excluded one study that met 
eligibility criteria but received a poor overall quality rating (See Appendix F). 
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Critical appraisal of included literature: 
Table 1 summarizes the quality ratings (including internal and external 
validity) for each of8 articles that received an overall rating of good or fair. I 
assigned quality ratings based on the categories of appraisal detailed in each full 
evidence table (Table 2a- 2h). The best evidence identified was a cross-
sectional, retrospective chart review conducted by Pinhas-Hamiel, Dolan, et al., to 
determine whether the recent rise in the diagnosis of type 2 DM corresponds with 
the rise in pediatric overweight. 5 
Internal Validity: 
The aforementioned study5 received a good quality rating for internal 
validity. The authors addressed selection bias by searching for all cases of type 2 
diabetes that were not diagnosed at their institution, the Children's Hospital 
Medical Center (CHMC) in Cincinnati, during the study time period. Only 12 
cases were diagnosed outside ofCHMC, compared to 1027 diagnosed within the 
institution. These 12 cases are unlikely to skew the results, and the potential for 
selection bias is low. This rating is based on the strict definition of the source 
population as those patients diagnosed with diabetes from 1982 to 1994 at 
CHMC. However, if the intended source population was all adolescents with type 
2 DM, the potential for selection bias increases due to possible undiagnosed 
"silent cases" that were not overweight. In other words, the authors could have 
selected a more overweight population of type2 diabetics because they were the 
ones who came to medical attention (truly a diagnostic bias). Even with moderate 
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selection bias, the internal validity of this study is good. The authors also 
addressed multiple confounders in their research methods, including: referral 
pattern, change in the total number of patients seen at CHMC, location of 
residence, and changes in ethnicity or other characteristics of the population over 
time. 
The remainder of studies had fair internal validity, primarily due to 
unacceptable potential for selection bias or confounding. For example, three 
authors excluded data on how the study population was chosen from the source 
population27-29; one author employed a selective recruitment strategy by 
advertising in the newspaper only; and one author did not report data needed to 
calculate attrition rates28 Measurement bias tended to be moderate in all studies 
because of the inherent subjectivity of anthropometric measurements and the 
unreliability of secondary data used to conduct retrospective reviews. 
External Validity: 
The leading study, by Pinhas-Hamiel, Dolan, eta!., 5 also received the only 
good quality rating for external validity. Authors used a relatively large sample 
size; accounted for all possible cases in their catchment area, which included 
more than one state; and showed that the incidence rates of type 2 DM at their 
institution were comparable to national rates. 
The remaining six studies had fair applicability to overweight adolescents 
in the United States. Several studies included children aged 12-19 years but did 
not stratify data by age categories to address adolescents21• 28• 30 One study 
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involved both children and adolescents, but had a mean age so low (11.8 +/- 0.5 
years) that the number of adolescent participants had to be minimal. 29 Two 
authors focused on a particular racial, ethnic, or high-risk group21• 27; thus, the 
results only relate to those specific groups. Finally, although the topic of this 
review lends itself to relatively few patients, studies with a particularly small 
1 . 9 29 31 1 l'k 1 h . 1 . f. samp e s1ze · · were east 1 e y to represent t e entire popu atwn o mterest. 
Overall Quality: 
Based on the ratings for internal and external validity, I rated 5 studies as 
fair, one study as fair/good, and one study as good. (see Table 1). In sum, the 
body of literature addressing adolescent overweight and type 2 DM is 
characterized by a limited number of studies with small sample sizes, inconsistent 
internal and external validity, and general methodological flaws. Using GRADE 
criteria23, the overall quality of evidence is essentially moderate -meaning that 
further research will likely have an important impact on confidence in the 
estimate of effect and may change the estimate. 
Summary of the Evidence: 
Key question: Within the U.S. adolescent population aged 12-19 years old, is 
overweight associated with the development of type 2 diabetes mellitus during 
adolescence? 
Two studies - one of good quality and one of fair quality - contained 
explicit language in their objectives that was pertinent to the key question above. 
The leading study, by Pinhas-Hamiel, Dolan, et al., sought "to determine whether 
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a rise in the diagnosis of noninsulin-dependent diabetes mellitus (NIDDM) has 
accompanied the rise in obesity in the pediatric population, as it has among 
adults."5 Lipton, Drum, eta!., aimed to determine the pathophysiology of 
childhood diabetes at onset, particularly in overweight children."21 
The commonalities of these studies include a large sample size, long study 
duration, and population-based approach. Also, each study involved a 
retrospective chart review and included both children as well as adolescents. 
Finally, as described in detail below, both analyses showed that well over 80% of 
children with type 2 DM (in these populations) were also overweight. Again, 
however, the inclusion ofumecognized, asymptomatic (i.e. non-overweight) cases 
may dilute this estimate. 
The first study, conducted by Pinhas-Hamiel, Dolan, et a!., received an 
overall quality rating of good. 5 The authors reviewed the charts of 1,027 
consecutive patients, aged 0-19 years, diagnosed with diabetes at CHMC from 
1982 to 1994. They used a computer database to identify clinical, demographic, 
and anthropometric data. 
Using National Diabetes Data Group standards (1979), the authors 
classified patients into one offour groups: ( 1) IDDM, heretofore referred to as 
type 1 DM; (2) NIDDM, heretofore referred to as type 2 DM; (3) secondary 
diabetes; and (4) impaired glucose tolerance. To evaluate weight status, the 
authors defined the 90th percentile BMI-for-age as 27 kg/m2 based on population 
data32• 33, and then reported the percentage of participants who fell at or above this 
BMl marker. 
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Fifty four out of 1,027 (5.3%) patients with diabetes met the criteria for 
type 2 DM. Among those aged 10-19 years, 33% of new cases were type 2 DM 
in 1994, compared to less than 10% before 1992. Although overweight was not a 
major impetus for presentation (only one patient was diagnosed during evaluation 
for overweight), the type 2 diabetic population was overwhelming overweight-
with a mean BMl of37.7 +/- 9.6 kg/ m25 In total, 92% had aBM12: 27 (the 90th 
percentile-for-age according to before mentioned data), 38% had a BMl > 40, and 
17%hadaBM1>45. 
Strengths of this study include a large total sample size and catchment 
area, a thorough assessment for potential confounders, and good internal and 
external validity (as discussed above). A major limitation, however, is that the 
authors did not report a test of correlation between BMl and type 2 DM, nor did 
they include data that would allow such a calculation. In the absence of this data, 
a direct association between overweight and type 2 DM cannot be quantified. 
The second study, conducted by Lipton, Drum, et a!., received a fair 
overall quality rating. 21 Researchers examined the medical records of 3 7 
Chicago area hospitals to find cases of type 2 DM initially diagnosed in 
individuals aged 0 to 17 years between 1985 and 2001. After limiting 
demographic criteria to African, Latino, or non-Hispanic white descent, a total of 
1242 records were available for review. 
The authors defined "obesity" (heretofore referred to as overweight) as a 
diagnosis written in the chart or BM12: 95th percentile by 2000 CDC growth chart 
standards. They defined diabetes by three categories. First, type 2 DM was 
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classified by a physician note containing "unusual, atypical, or possible type 2"21, 
the presence of acanthosis nigricans or polycystic ovarian syndrome, current oral 
medication use, or any patient who quit insulin treatment without experiencing 
diabetic ketoacidosis after at least six months duration. Second, obesity-related I 
undetermined type DM was classified by a physician note containing "obese"21 or 
BM12: 95th percentile, and no other indicators of type 2 DM. All others were 
classified as type 1 DM21 
Of the 1242 diabetic children studied, 27.9% were overweight. None of 
the patients with type 1 DM were classified as overweight. In contrast, 73.4% of 
type 2 diabetics and 100% of obesity-related I undetermined type diabetics were 
overweight21 In total, then, 86.5% of non-type 1 diabetics were overweight. 
The rates of overweight for individuals aged 12 to 19 cannot be ascertained 
because the authors did not stratify results by age. However, average age at 
diagnosis for type 2 DM was 13.6 years (SD 2.9)- and 12.5 years (SD 3.5) for 
obesity-related I undetermined type diabetes21 Thus, while adolescents 
comprised the majority of individuals with type 2 DM, the total non- type 1 
diabetic population included some individuals too young for such classification. 
Strengths of this study include hosting a relatively large, population-based 
sample (n=1242) and covering medical records from an extensive time frame 
(1985 to 2001 ). However, the potential for misclassification of diabetes I 
overweight status and ethnicity cannot be ignored. The definitions and methods 
used to define each of these categories were not based solely on accepted 
standards. Also, in multivariate models comparing type 1 vs. type 2 DM or type 
17 
1& 2 vs. obesity-related I undetermined type diabetes, the authors did not 
calculate an odds ratio for overweight as a predictor of type 2 DM 
Together, these data indicate a substantially higher rate of overweight in 
adolescent patients with type 2 DM compared to those with type 1 DM. 
Collectively, these studies support a relationship between overweight and type 2 
DM among adolescents; but, they do not have the appropriate measures of 
association to make a conclusive statement. 
Subcomponent of Key Question: Within the U.S. adolescent population aged 12-
19 years old, is overweight associated with the development of precursors to type 
2 diabetes mellitus during adolescence - namely insulin resistance or 
insensitivity, impaired glucose tolerance (JGT), or hyperinsulinism? 
The remaining 6 studies were not directly applicable to the key question of 
this systematic review. Rather, they addressed a relevant subtopic within the 
association of adolescent overweight and type 2 DM. One prospective 
longitudinal cohort study examined impaired glucose tolerance28; two cross-
sectional studies looked at insulin insensitivity"· 29; one prospective longitudinal 
cohort and one cross-sectional study addressed hyperinsulinism27• 30; and one 
cross-sectional study examined various physical, behavioral, and environmental 
features of adolescents already diagnosed with type 2 DM31 
18 
Impaired glucose tolerance 
Weiss, Taksali, et al., prospectively evaluated 117 overweight children 
and adolescents - aged 4 to 18 years old - who were considered to be at risk for 
diabetes. They defined overweight as BMI :::: 95th percentile according to 2000 
CDC growth charts. Participants completed an oral glucose tolerance test and 
standardized lab evaluations in order to be classified as normal versus impaired 
glucose tolerance (NGT vs. IGT) or diagnosed with type 2 DM. For 18 to 24 
months, researchers followed 84 participants who had normal glucose tolerance at 
baseline and another 33 with baseline impaired glucose tolerance28 
Of the 117 overweight participants in the initial cohort, 8 (6.8%) 
developed type 2 DM28 All 8 of these patients had IGT at study baseline, 
suggesting that IGT is a "pre-diabetic" state28 None of the participants who 
entered the study with normal glucose tolerance went on to develop type 2 DM. 
However, 8 (9.5%) of these participants did develop impaired glucose tolerance. 
Analysis of the patients who developed type 2 DM revealed that they had 
significantly higher BMI and BMI z scores than the other groups (P=0.006)28 
Furthermore, among subjects with IGT, the BMI z score was significantly greater 
in those who developed T2DM (2.76 +/- 0.21 vs. 2.32 +/- 0.40, P=0.001). 28 In a 
subgroup analysis of subjects with initial IGT, participants who developed type 2 
DM were significantly more overweight (mean BMI 44.8 +/- 9 vs. 33.1 +/- 6.9 
P=0.01) at baseline; gained a significantly larger amount of weight (27.3kg +/-
23.1 vs. 6.1kg +/- 8.4; P=0.006); and increased their BMI (6.80 kg/m2 +/- 7.08 vs. 
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1.06 +/- 2.56; P=0.025) more during the course of the study than those who 
reverted to NGT. 
The data in this study arise from a methodologically sound background; 
however, the study is limited by incomplete reporting of data to calculate attrition 
rates and lack of age-specific measures of association. Also, the mean age of 
participants (12.5 +/- 3.2 years with NGT and 12.7 +/- 2.7 years with IGT) 28 
suggests that many of the individuals included in data analysis do not belong in 
the adolescent category. 
Insulin insensitivity 
Two authors conducted cross-sectional studies pertaining to insulin 
sensitivity in overweight children and adolescents. Bacha, Saad, et al., used 
hyperglycemic and hyper- insulinemic euglycemic clamps and compared African 
American and white overweight adolescents with a mean age of 13.4 +I- 0.3 years 
to 13.3 +I- 0.4 years, respectively9 Tershakoec, Kuppler, eta!., also compared 
African American and white participants, but evaluated the homeostasis model 
assessment of insulin sensitivity (HOMA-IR) in children and adolescents aged 6-
18 years old (mean age 11.8 +/- 0.5 years)29 
In a sample of 50 subjects, Bacha, Saad, et a!., found that insulin 
sensitivity, insulin clearance, and first phase insulin were not different between 
overweight African American and white adolescents9 Yet second phase insulin 
secretion was higher in whites compared to blacks (2015.4 +/- 180.6 vs. 1468.7 
+!- 102.8 pmol/liter; P=0.01)9 White overweight adolescents also had higher 
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lipid levels, more hepatic glucose production, and more visceral fat than their 
black counterparts- all of which were considered to be diabetogenic factors. 
In a sample of36 participants, Tershakoec, Kuppler, et al., found that 
insulin & HOMA-IR levels were significantly associated with fat mass (Spearman 
r=0.40; P=0.03; and r=0.38; P=0.04) and leptin (Spearman r =0.73; P<0.0001)29 
However, ethnic group differences in fat mass (abdominal and visceral), 
subcutaneous fat, insulin level, and HOMA-IR were not significant after adjusting 
for age & pubertal status. 
Both of these fair quality studies are limited by a small sample size. With 
a focus on comparing ethnic groups, these data contribute little to an association 
between overweight and precursors of diabetes in adolescence. Further 
limitations include an unspecified time frame of recruitment29 and lack of age-
stratified data. 
Hyperinsulinism 
Two fair quality studies tackled the association of hyperinsulinism with 
diabetes in young populations. The first, conducted by Anavian, Brenner, eta!., 
aimed to investigate how often overweight in childhood is associated with 
common metabolic abnormalities, including hyperglycemia and 
hyperinsulinism30. Authors reviewed the charts of 106 overweight individuals 
aged 3 to 18 years who were referred for endocrine or metabolic evaluation at 
North Shore Hospital (New York). Between 1993 and 1998, a total of 43 
overweight adolescents were included in the study: 14 individuals aged >12 to 14 
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years (mean BMI 35; SD 2.4) and 29 individuals aged >14 to 19 years (mean 
BMI 37.8; SD 2.4)30 
This study noted a direct relationship between age and abnormal insulin-
to-glucose ratio (>1:4). For example, no one aged 3 to 8 had an abnormal ratio; 
yet, 34% of those aged 14 to 19 did (P<0.01)30 While the older age group also 
had the highest BMI values, the authors did not draw a direct correlation between 
overweight and an abnormal ratio. 
Serious limitations of this study include a short, descriptive, and 
incomplete results section; and use of crude BMI and ideal body weight (lBW) 
rather than BMI percentiles-for-age (which were appropriately defined by the 
authors). 
The second study, conducted by McCance, Pettitt, et al., sought, in part, 
to answer the question "Does hyperinsulinaemia in childhood & adolescence 
predict diabetes?"27 Authors reported data from a prospective longitudinal study 
amongst a cohort of 5 to 19 year-old Pima Indians (Gila River, Arizona) with at 
least one diabetic parent. Of 1,120 subjects who entered the study between 1973 
and 1986, 9% developed diabetes during a mean 8.4 yrs offollow-up27 
Adjusted for age and sex, relative weight was more predictive of diabetes 
mellitus than any other measure: relative weight IRR=2.59 (95%CI 1.66-
4.04;P<0.001) vs. 2-hour glucose: IRR=2.41 (95%CI 1.26-4.59;P=0.008) vs. 
fasting glucose: IRR=1.67 (95%CI 1.16-4.04;P=0.005)27 
The main limitation of this study is a lack of generalizability to 
populations other than high-risk, Pima Indian youth. Also, the authors used 
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relative weight as an index of "obesity" based on World Health Organization 
standards rather than calculated BMI values. 
Additional physical, behavioral, and environmental features: 
Pinhas-Hamiel, Standiford, et al., conducted a cross-sectional analysis of 
42 patients who's type 2 DM was previously diagnosed at Children's Hospital 
Medical Center (Cincinatti). 31 Subjects were age 11 to 17 years old, and both 
parents were required to participate. The researchers' main objective was "to 
identify physical, behavioral, & environmental features" these patients and their 
families to help "define involvement of known risk factors and to define a profile 
of at-risk individuals."31 
Outcome measurements included BMI, skinfold thickness, waist-to-hip 
circumference, and a dietary intake questionnaire (administered by a dietitian). 
Overall, participants were overweight (mean BMI of 37 +/- 11 kg/m2) and had 
anthropometric measurements consistent with central obesity. However, the 
authors' assessment is primarily qualitative. They conclude that adolescents with 
type 2 DM, as well as their families, have marked central obesity, a sedentary 
lifestyle, and poor dietary habits. 31 
The small sample size of this study limits the application of results to 
other adolescents with type 2 DM. Also, the classification of overweight is 
questionable because only crude BMI values are reported (though the authors 
state that all participants had a BMI >95th percentile)31 
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Non-quantitative Data Synthesis: 
Table 1 summarizes the descriptive elements of reviewed studies. Due to 
widespread heterogeneity, a numerical estimate of effect could not be calculated. 
Discussion 
Principal findings: 
The body ofliterature addressing adolescent overweight and type 2 DM is 
characterized by a paucity of studies, inconsistent validity, and general 
methodological flaws. Also, many of studies that include adolescents as well as 
other age groups do not contain subgroup analysis by age. In spite of these 
limitations, the findings of this systematic review are generally consistent. That 
is, the publications reviewed do suggest a relationship between adolescent 
overweight and type 2 DM. This association is demonstrated, in part, by frequent 
coexistence of the conditions and/or probable precursors. 
The data indicate that a considerable proportion of young patients with 
diagnosed type 2 DM are also overweight. For example, in one study, 92% of the 
adolescents with type 2 DM had a BMI ~ 275 (A BMI of27 corresponds to the 
90th percentile-for-age5, putting these patients in the at risk for overweight 
category.) Another study which addressed both type 1 and type 2 diabetics found 
that only those with type 2 DM were overweight.Z1 However, no study addressed 
identification of"silent cases" in the adolescent population; if there are a 
substantial number of silent cases, then considerable selection bias could 
exaggerate the association of overweight with type 2 DM. ( Overweight is a 
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typical indication for screening; thus, overweight adolescents are more likely to 
be screened and therefore diagnosed during a silent phase of the disease process.) 
The data also suggest that overweight adolescents are prone to having 
metabolic disturbances that may be related to type 2 DM. For example, Weiss 
found that among subjects with impaired glucose tolerance (IGT), those who 
eventually developed type 2 DM had significantly greater BMI z scores than those 
who did not28 In the same study, all of the patients who developed type 2 DM 
had IGT at baseline, while none of those with normal glucose tolerance (NGT) 
developed type 2 DM. 28 Extrapolation of Weiss' findings indicate that 9.5% of 
overweight children & adolescents with NGT develop IGT, and that 24.2% of 
patients with IGT develop type 2 DM. 
However, a causal pathway must include a measure of temporality. The 
current data do not directly state that overweight status comes before the 
development of type 2 DM; nor do the data specifically draw a chronological line 
from being overweight, to developing IGT or hyperinsulinism, to developing type 
2DM. 
Limitations of current systematic review: 
To my knowledge, no published systematic review addresses the 
association between adolescent overweight and type 2 DM in the U.S. Hence the 
findings of this review cannot be compared to previous work of similar design. 
However, internal assessment reveals several limitations. 
First, I intentionally limited the data in this systematic review to U.S. 
populations. Although my specific question pertained to U.S. adolescents, data 
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from other countries may help to define an applicable association. Numerous 
studies, from the United Kingdom (UK), Germany, Japan, Australia, and others, 
tackle the rising incidence of adolescent overweight and/or type 2 DM. Based on 
the criteria used in this systematic review, none directly addressed the key 
question (see 'Other Considerations' section below). 
Also, I attempted to reduce retrieval bias by conducting multiple literature 
searches through several media. With additional time and resources, inclusion of 
other commonly cited databases (such as EMBASE or PsyciNFO) may prove 
useful. Similarly, inclusion of studies not published in English may offer added 
insight. 
Finally, this systematic review could be expanded to address a number of 
questions relevant to the key question. For example, does prevalence of 
adolescent overweight and type 2 DM differ by ethnicity, age, or sex? How well 
do impaired glucose tolerance and insulin resistance predict the development of 
type 2 DM in adolescents? Exploration of these and other related queries will 
help refine the implications of the current review. 
Limitations of identified literature 
The body ofliterature pertaining to the association between overweight 
adolescents and adolescents with type 2 DM in the United States has important 
deficiencies. First, and foremost, few studies actually directly address this 
association. In this systematic review, only two publications had specifically 
relevant objectives. 5• 21 However, neither study reported data that would allow 
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calculation of risk profiles or even ratios of association. The remaining studies 
addressed a surrogate measure of type 2 DM, such as insulin resistance or 
impaired glucose tolerance. 
Focusing on presumed precursors of type 2 DM in adolescents presents a 
second major limitation of the literature. To date, no studies have confirmed that 
the precursors known to be risk factors for type 2 DM in adults are also predictors 
of type 2 DM in adolescents. Therefore, even if a strong association is noted 
between overweight adolescents and, for example, insulin resistance, one cannot 
assume that there is also be a strong association between overweight adolescents 
and type 2 DM. 
Furthermore, the available data are generally comprised of studies with a 
small sample size. Admittedly, both overweight and type 2 DM are relatively 
novel conditions within the field of pediatrics; correspondingly the pool from 
which to derive research populations is relatively small. 
Other considerations: 
International Efforts 
Surveillance of literature conducted outside the U.S. reveals that pediatric 
overweight and type 2 DM are global concerns. Much like the case in the U.S., 
other countries lack exact data on prevalence. One European review states that a 
"reportedly high" prevalence of type 2 DM in some Australian ethnic groups is 
linked very closely to "obesity. "34 The same authors found incongruent estimates 
of type 2 DM prevalence in German children under the age of 15.34 Another 
German study found type 2 DM in 1.5% of 520 children and adolescents 
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consecutively admitted to an in-patient obesity unit.35 A Japanese study of22 
patients with type 2 diabetes mellitus (age at diagnosis less than 18 years) found 
the majority (n=17) to be obese at onset of disease36 And a study of Thai 
children and adolescents found that the prevalence of type 2 DM increased from 
5% during 1986-1995 to 17.9% during 1996-1999 with mean BMI of27.8 
kg/m2 37 No studies provide a precise, population-based estimate of type 2 DM 
prevalence or incidence amongst overweight adolescents. 
Also, the international literature does not directly address an association 
between overweight and type 2 DM. Instead, authors focus on intermediate 
metabolic disturbances. One study, conducted by Wiegand et al., in a Caucasian 
European cohort of children and adolescents with "obesity" sought to determine 
the prevalence ofiGT and type 2 DM. 38 Out of 102 patients, 37 had IGT and 6 
were diagnosed with type 2 DM38 Among adolescents with IGT, the prevalence 
of type 2 DM in this study (5.9%) is very similar to that reported in the U.S. by 
Weiss, et al., (6.8%)28 Interestingly, a study out ofJapan found insulin resistance 
to be a factor in development of adolescent type 2 diabetes, regardless of weight 
status ("obese" vs. "non-obese")36 
Finally, similar to U.S. authors, researchers elsewhere have approached 
the rising prevalence of type 2 DM by comparing it to type 1 DM. For example, a 
study of pediatric subject in the UK found, "in contrast to type 1, type 2 patients 
presented later (12.8 v 9.3 years), were usually female, overweight, or obese (92% 
v 28%), and a greater proportion were of ethnic minority origin (56% v 22%)."39 
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These authors estimate the crude minimum UK prevalence of type 2 diabetes 
under 16 years to be 0.21/100 00039 
BMI as measure of overweight: 
The American Academy of Pediatrics (AAP) recently published a 
systematic review of evidence for screening and interventions for childhood 
overweight. 12 They found that BMI is the most frequently used measure in 
prevalence data and trends because it is considered to be valid, gathered 
consistently in surveys, and uses a single source for comparison. Though the 
authors do not explicitly state a recommendation, they endorse use of the CDC 
gender-specific BMI growth chart. 12 
Even as the most widely recommended measurement tool, BMI has 
several limitations. Authors disagree on its sensitivity, specificity, and 
effectiveness compared to other measures. 40' 41 Also, BMI percentile-for -age is a 
norm-referenced standard. As the population continues to increase in size, the 
normal standard will increase and perhaps represent a less healthy state than it 
currently does. Finally, utilization ofBMI charts in the U.S is not yet universal. 
For example, in a study wherein BMI charting heightened recognition of 
overweight, pediatrician usage was infrequent and irregular - with 31% of 
clinicians reporting no prior usage ofBMI. 42 
Nonetheless, BMI may be a particularly relevant tool in the adolescent 
population given its increased tracking with age. BMI tracking from childhood to 
adulthood is correlated fairly well in ages 6-18 (r=0.2-0.8). And, correlation 
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increases (to an r?:: 0.6) in children older than 8 years, those with an obese parent, 
and younger children who are more overweight (above 95 or 98%ile)12 
Implications for healthcare policy 
Current policy related to overweight adolescents includes screening for 
diabetes. As of2000, the American Diabetes Association (ADA) recommends 
testing children for diabetes if aged ?:: 10 years with a BMI >85th percentile for age 
and at least 2 other risk factors. 43' 44 These risk factors include positive family 
history of type 2 DM, signs of insulin resistance (acanthosis nigricans, 
dyslipidemia, hypertension, polycystic ovarian syndrome) or an ethnic 
predisposition. 38' 44 
The validity of this recommendation is unclear. Based on the results of this 
systematic review, there is insufficient evidence to strongly support the ADA's 
screening policy. Although it seems logical to screen overweight adolescents for 
diabetes given that those with type 2 DM tend to be overweight, the concrete 
evidence does not exist. Also, the ADA's use of the term "risk factors" may be 
premature in the absence of studies confirming precursors of diabetes in the 
pediatric subset. Finally, the effectiveness of screening remains to be seen. In a 
European study, for example, the authors assert that "Using the screening 
algorithm for type 2 diabetes as advocated by the American Diabetes Association, 
68% of patients with impaired glucose tolerance and 66% of patients with type 2 
diabetes would have been missed."38 
The pediatric field is in need of truly evidence-based practice guidelines 
regarding adolescent overweight and type 2 DM. Once standards are in place, 
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policymakers must adapt the education training programs of health care providers 
who care for children and adolescents. Before any of this can happen, there needs 
to be adequate data from well though out research studies. 
Implications for Future research: 
Given a general lack of direct evidence, the focus on intermediate 
outcomes, overall low quality, and questionable generalizability of current 
literature, the implications for future research are many. 
Establishing Prevalence of Type 2 DM: 
• Plentiful data exist regarding prevalence and incidence of adolescent 
overweight in the U.S. This is not the case for type 2 DM, where the true 
burden of suffering has yet to be determined. A population-based, cross-
sectional analysis is needed in order to identify children with Type 2 DM 
regardless of whether they have been diagnosed (i.e., in order to include 
"silent cases"). 
• Also, researchers will need to account for biases that may affect diagnosis. 
For example, in one study, significantly fewer children classified with 
obesity-related I undetermined type diabetes were diagnosed at a tertiary 
care center compared to type 2 DM (P=0.024) and type 1 DM (P=0.017). 
21 The often asymptomatic nature of type 2 DM means that a number of 
affected patients may never be referred to tertiary care. The potential for 
hidden prevalence is high. Future research should be population-based 
and address differences in diagnosis patterns based on tertiary versus 
community setting. 
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Defining Metabolic Precursors of type 2 DM: 
• It is unclear "whether impaired glucose tolerance or insulin resistance is a 
risk factor for T2DM in children as it is in adults."45 Given the scarcity of 
data regarding type 2 DM in the pediatric population, assessment of 
potential metabolic precursors is a logical starting point. 
Establishing an Association between Overweight & type 2 DM: 
• To actually quantify the degree to which overweight contributes to type 2 
DM risk, future studies should be designed with the optimal degrees of 
association in mind. These include cumulative incidence and relative risk 
I rate ratio. 
• A fundamental question is what is the most appropriate way to approach 
the key question of this review. Should researchers start with a cohort of 
overweight adolescents and then look for the development of type 2 DM? 
Or should a cohort of adolescents with type 2 DM be examined for 
overweight trends? 
• I believe the best approach is to start with a population of healthy 
adolescents. This cohort should be followed over time for the 
development of type 2 DM and then assessed for potential risk factors 
(e.g. BMI, diet, family history, etc.). 
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o To assess causality the ideal study must be of sufficient duration to 
ascertain a temporal relationship. Since adolescence is the time 
period of interest, I recommend emollment by age 5. 
o Causality would be most supported if non-overweight children 
develop overweight and later develop type 2 DM during 
adolescence. 
Implications for the health of U.S. adolescents 
• The health of overweight adolescents lags behind that of their normal-
weight counterparts. "Among adolescents, a BMI higher than the 85th 
percentile for age and sex has been associated with a significant health 
risk, particularly if there is the additional feature of a family history of 
type 2 diabetes31' 46 
• A number of unanswered questions remain: Is there a genetic 
predisposition to overweight and type 2 DM? How strong? To truly 
establish causality, can a temporal relationship be deciphered? Should 
only high risk patients be screened? Is there any mortality data? 
Conclusion 
Insufficient evidence is currently available to conclude reliably on a causal 
association between overweight status and development of type 2 DM in 
adolescence. However, the selected results identified by this review support such 
an association. For example, the data indicate that a considerable proportion of 
young patients with type 2 DM are also overweight. 5' 21 The data also suggest that 
33 
overweight adolescents are prone to having metabolic disturbances that may be 
related to type 2 DM28 Further research will need to clarify the diagnoses of 
type 2 DM, involve population-based sampling, and specifically target the 
adolescent age group. 
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Table 1. Summary of Evidence Quality Review 
Author Sample Ages Outcome Results Internal/External Overall 
Size (years) Measures Validity 
Pinhas~Hamiel 0, 1,027 0-19 BMI,DM -54/1027 had T2DM Good /Good Good 
et a1.,5 -92% of these had BMI ~90th% 
Lipton RB, 1,242 0-17 BMI -27.9% of diabetics 0/W Fair I Fair Fair 
et al.21 -86.5% of non-type 1 diabetics 0/W 
Weiss R, 117 4-18 BMI,OGTT -6.8% developed T2DM Fair I Fair-Good Fair 
et al.28 & had significantly higher BMI 
Bacha F, 50 mean 13.4 VAT,SAT, -insulin sensitivity not different Fair I Fair Fair 
et at./' clamp b/w blacks & whites 
Tershakovec AM, 36 6-18 BMI, HOMA-IR -Insulin & HOMA-IR levels Fair I Fair Fair 
et al.,2!1 significantly associated w/ fat mass 
Anavian J, 106 3-18 BMI, labs - Direct relationship b/w age Fair-Poor I Fair Fair 
et al./0 & abnormal insulin:glucose ratio (>1:4). 
McCance DR, 677 5-19 Relative wt., -9% developed T2DM Fair I Fair Fair 
et al.27 DM -relative wt. most predictive 
Pinhas-Hamiel 0, 42 11-17 BMI -common trend of central obesity Fair I Fair Fair 
et al.,31 poor diet, sedentary lifestyle 
BMI: Body Mass Index; T2DM: type 2 diabetes mellitus; DM: Diabetes Mellitus standard diagnostic criteria; 0/W: overweight; OGTT: oral glucose tolerance test; VAT: visceral adipose tissue; SAT: 
subcutatneous abdominal adipose tissue; HOMA-IR: homeostasis model assessment of insulin sensitivity 
39 
Table 2a. Evidence Table with Quality Review 
Reference # 5 
·. I 
Citation Objective Population: Population: Groups Drop outs Selection 1 Measurements 
Measurement 
Design Total N Eligibility criteria & comparable? bias . bias potential? 
Setting Duration Demographics I potential? 
Source . . . 
Pinhas- To determine N- 1027 Ages: 0-19y Classified by National N/A LOW-MOD Computer database MODERATE 
Hamiel 0, whether a rise records Diabetes Data Group to ID clinical, 
DolauLM, in the dxof Iuclusiou: all source (1979) as: Only 12DM demographic, and Are 1979 l)IDDM standards 
et al.,5 "NIDDM'' has 13 yrs population records 2)NIDDM cases were missed anthropometric data outdated at time b/c they were not 
accompanied 3)Secondary diabetes diagnosed at ofthis study? 
Increased the rise in Source= 4)1GT CHMC. These 12 Used standard 
incidence obesity in the consecutive cases compared to diagnostic criteria Reliance on 
of non- pediatric patients with 1027 would be 
secondary data 
unlikely to skew insulin- population, as DxofDM the results 
dependent it has among from 1982 to significantly. 
diabetes adults. 1994 at this However, if 
mellitus hospital source is defmed 
among Retrospective as all w/ type 2 DM, then 
adolescents chart review asymptomatic 
"silent cases" 
1996 University- would be missed. 
Those selected 
affiliated ped may then be more 
diabetes overweight b/c 
referral they have this 
center: reason to be 
CHMC screened for DM. 
-
. 
-
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. 
Potential Confound in Analysis Results: magnitude and .. Internal validity External Overall Comments 
confounders & g potential? direction rating validity quality rating 
corrections . . rating . 
LOW Chi-sq 54/1027 patients w/ DM met criteria for GOOD GOOD GOOD Didn't calculate OR 
Referral pattern, ANOVA type 2 for BMI, but did so for 
changes in total # of B/c well ANCOVA Relatively African Americans by Among age 10-19,33% of new cases were sex. 
Pts, cases not seen at controlled for NIDDM in 1994, compared to 3-10% large total 
this hospital, changes in or explained BMI not before 1992. The population of children sample; 
ethnicity/other in results I normally this age seen at CHMC remained stable accounted for 
characteristics of discussion distributed, throughout the time frame. all possible 
population, location of so used log Obesity was not a major reason for cases; 
residence transform- presentation only 1 Pt was diagnosed catchment 
ationfor during an evaluation for obesity. area includes 
All of the above parametric Mean age at NIDDM dx"" 13.8 +/-1.9 more than 
addressed by analyses one state; 
researchers MeanBMI in NIDDM = 37.7 +/- 9.6 kg/ incidence 
m' rates at [The 90th %ile is 27 for the pediatric CHMCare population as a whole (see refs)J 
47/54(92%)hadBMI:0:27(90 %ile) close to 
21 (38%) had BMI > 40 national rates 
9 (17%)had BMI >45 (p.609) 
Direction: positive association between 
overweight and type 2 DM 
,; Dietary intake 
,; Genetics 
,; Puberty (b/c 
causes wt gain 
& transient 
insulin 
resistance?) 
,; Metabolic dz 
,; Sex? 
-
L 
·--- --- -- - - ---- -- -- --
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Table 2b. Evidence Table with Quality Review 
Reference # 21 
.. I Measuremen Citation Objective Population: Population: Groups Drop outs Selection Measurements t biaS Design Total N Eligibility criteria & comparable? bias potential? 
Setting Duration Demographics potential? 
Source . . . 
LiptonRB, To determine N 1599 Ages: 0-17 at initial N/ A: no control vs. N/A MODERATE ~Medical record review by MODERATE 
DrumM,et pathophys of (calculated) diabetes dx experimental/case assistants (handwritten & 
al..21 childhood groups. However, -Prior to PDA) All done by 1985-2001 compared based on dz -Standardized interviews chart review, 
diabetes at Medical record review category: 111/92, by telephone so potential for 
Obesity at onset, Chicago at 37/40 hospitals w/ registry inter and intra-
the onset of particolarly in Childhood peds ward & >200 Average age at included only T2DM: MD note rate Diabetes Registry: diagnosis= 13.6 (SD contained ''unusual, differences is diabetes in o/w children a population- inpatient beds 2.9) in T2 DM vs. 9.7 blacks & atypical, or possible type high. But, no 
an based registry of (SD 4.6) in TIDM Latinos who 2"; had AN or PCOS; on other 
ethnically kids age 0-17 at Inclusion: dx 111185 wereD/C'ed interview, Pt quit insulin measurement 
diverse Cross-sxnal initial dx; all on; resident of T2DM more likely to on insulin.; w/o DKA after >6 mo option given 
popnlation b/c looked at African, Latino, or Chicago, have comorbidities, after 1992, duration, currently on retrospective non~Hispanic Medicaid, or be pills. nature. 
of children: incidence rates white descent uninsured. whites The interview 
What does per year? included and Obesity~related/ only aided Dx 
it mean for (1985-2001) Plus numerous n= 1242 records The type 2 DM group tx didn't Wldetermined type DM: oftype2 DM. 
epidemiolo secondary sources available also contained a higher matter. MD note states obese" or Misclassifi-of cases percentage of non~ BMI_::::95% (CDC) & no cation ofDz & 
gists and ~N~-~~------------- Hispanic blacks -All cases had other indicator oftype 2 obesity status 
clinicians? [Source = all n=262 = subset for (76.4%) and girls to have been type quite 
Chicago kids as interviews (59.6%) than the type hospitalized. TlDM: all others possible. 
above] 1 group (54.4% and 2005 49.8%, respectively). Would this Obesity: BMI?. 95th or dx 
n=203 probable T2DM miss anyone? written in chart 
-population-
based is good 
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Potential confounders Confounding Analysis Results: magnitude and Internal validity External Overall quality Comments 
& corrections potential? direction rating · validity rating 
. rating 
MODERATE -Univariate Of the 1242 diabetic children FAIR FAIR FAlR Strengths: 
Source of medical care: -Multiple stndied, 27.9% were overweight. ..Covers a long period 
of time 
adjusted for tertiary vs. logistic Interestingly, none of the patients Applicable ~Large sample size 
community facility regression with type 1 diabetes were classified maiulyto 2 given rare diagnoses 
as overweight. In contrast, 73.4% specific MPopulation-based 
Year of onsetldx: of type 2 diabetics and 100% of minority 
Limitations 
adjusted for in all obesity-related I undetermined type populations 
-Do not give age 
models diabetics were overweight In total, specific rates 
then, 86.5% of non-type 1 diabetics -Did not use measures 
Ethnicity definitions were overweight. of association 
-Not sure how to 
were self-labeled. But interpret the middle 
those w/ Hispanic Looking at time trends, the category- which was 
surname who classified proportion of type 2 diabetics essentially a construct 
themselves as non- classified as overweight increased ofthe authors. 
-In multivariate models Hispanic (black or in the latter years of the stndy. comparing type 1 vs. 
white) were considered type 2 DM or type 1& 2 
to be Latino. Surname vs. undetennined, there 
could represent mother's was no mention of 
remarriage not true obesity as a predictor. 
ethnicity 
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Table 2c. Evidence Table with Quality Review 
Reference # 28 
. . 
Citation Objective Population: Population: Groups Drop outs Selection Measurements Measuremen 
Design Total N Eligibility criteria & comparable? bias !bias 
Setting Duration Demographics potential? potential? 
Source . ·.· . ·. . .. 
To examine N- 129 Ages: 4-18 YES NR MODERATE Patients followed LOW 
Weiss R, which clinical, n=90normal N=ll7 Sex, age, height, biannually; OGTT Taksali SE, metabolic & glucose n=84NGT Must assume Unclear repeated at 18-24 OGTT 
et al. 28 anthropometic tolerance n=33 IGT weight, BMI, BMI that the 117 in exactly how months; used methods & lab 
parameters (NGT) Inclusion: BMI>95% z score the original patients were standard blood analysis well 
Predictors may serve as n=39 impaired (CDC); normal 
Baseline NGT vs. 
cohort remained recruited from sampling and lab described. 
of changes useful GT (IGT) thryroid clinic & no analysis 
in glucose predictors of IGT: data on how All labs went 
tolerance change in 18-24 months? Exclusion: those on 
Age 12.7(3.2) v. many refused Defined NGT, IGT, to same place 
status in glucose meds or w/ dz that & T2DM based on 
obese metabolism in Yale Pediatric affects glucose 12.5(2.7) lab values 
youth obese children Obesity Clinic metabolism; 
NO & adolescents [patients w/ 
Ethnicity: 28.6% 2005 at risk for informed 
diabetes consent of AA vs. 39.4%; 
parent and 25.0% Hispanic 
Prospective, assent of VS. 12.1% 
longitudinal patient] 
cohort 
Outpatient 
clinic 
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Potential confounders Confounding Analysis Results: magnitude and Internal validity External Overall quality Comments 
& corrections potential? direction rating validity rating 
. rating .. .· 
MOD-HIGH t-test, -Of 117, 8(6.8%) developed type 2 DM. All FAIR FAIR-GOOD FAIR Regression 
All included in linear Mann- 8 had IGT at study baseline. None who interpretation 
regression models: WhitneyU entered the study with NOT developed Selection bias This cohort of unclear? T2DM. However, 8 (9.5%) did develop IGT. 
Age test, & These data indicate that 9.5% of obese possible, but data obese children 
Sex linear children & adolescents with normal glucose not given. & adolescents Again, no age 
Initial glucose level regression. tolerance develop impaired glucose tolerance, likely specific data, 
BMI, etc Poorly and that 24.2% of patients with impaired represent therefore cannot glucose tolerance develop type 2 DM. 
described ~Majority of patients- 90.5% of the originally most. No make statements 
Time of follow-up: is NGT and 45.5% of the initially IGT- had reason to about adolescents 
18-24 months an NGT by study end. think they're alone. 
equivalent enough time -Of the 8 patients who developed T2DM biologically *87.5% =AA female 
frame or should flu be *had significantly higher BMI and BMI z different than Semi-small sample 
closer (e.g. 22-24 mo) scores than the other participants others. size. No mention 
(P~0.006). of power analysis 
-Comparing only subjects with IGT, BMI z (other than significantly greater in those who developed 
T2DM (2.76 +/- 0.21 vs. 2.32 +/- 0.40, inability to address 
P=O.OO!) ethnicity) 
-Subgroup analysis initial IGT: participants 
who developed T2DM were significantly 
more overweight (mean BMI 44.8 +1- 9 vs. 
33.1 +/- 6.9 P=O.O 1) at baseline, gained a 
significantly larger amount of weight (27.3kg 
+/- 23.1 vs. 6.lkg +/- 8.4; P~0.006)and 
increased their BMI (6.80 kglm2 +/- 7.08 vs. 
1.06 +/- 2.56; P=0.025) during the course of 
the study. 
Every 1 unit change in BMI z score resulted 
in 10.9 mg/dl change in glucose level. 
--
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Table 2d. Evidence Table with Quality Review 
Reference # 9 
.. 
Citation Objective Population: Population: Groups Drop outs Selection Measurements Measuremen 
Design Total N Eligibility criteria & comparable? bias t bias 
Setting Duration Demographics potential? potential? 
Source . 
. .... 
. .. . 
BachaF, To investigate N- 50 Ages: "adolescent" Divided into BOA N/A IDGH Puberty: by Tanner LOW 
SaadR, et insulin sensitivity Mean 13.4 (+/- 0.3) andWOA assessment 
a1.,9 & secretion. CVD N/A BOA vs. 13.3 (+/· 0.4) Volunteers confirmed w/ sex- Measurements risk profile, & 
visceral adipose WOA YES on age, appropriate labs generally 
Obesity, tissue (VAT) Recruited via n=24BOA tanner, BMI, fat Had to have standardized 
Regional fat /syndrome X newspaper ads n=26WOA mass, %body fat parents who Clamp stndies and/or distribution, & relationships in 
syndrome X in black vs. white read the verifiable 
obese black obese adolescents Inclusion: parental NO newspaper Body composition: 
vs. white (BOA vs. WOA) consent, child assent, WOAhad DEXAscan 
adolescents: good health by significantly 
race CrossRsxnal: 
differential in Each Pt had a history/PE/labs, on no higher visceral Snbcntatneous 
diabetogenic hyperglycemic meds, obese adipose tissue abdominal adipose 
and clamp & a hyper- (88.3 +/- 7.9 vs. tissue (SAT) and 
artherogenic insulinemic 60.2 +!- 5.8; VAT: single slice CT 
risk factors euglycemic clamp 
study performed P=0.006)-
2003 in random order at especially white Various lab & 1-to 2- week males biochemical 
intervals. measures 
Community based 
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. 
Potential confounders Confounding Analysis Results: magnitude and Internal validity External Overall quality Comments .· 
& corrections potential? direction rating validity rating 
. . rating 
Age, Tanner stage, MODERATE t-test, In a sample of 50 subjects, found FAIR FAIR FAIR Primarily 
baseline BMI: multivariate that insulin sensitivity, insulin intermediate 
, bivariate, clearance, and ftrst phase insulin outcomes. 
All were similar regression were not different between 
between groups at overweight African American and 
baseline white adolescents. Yet second 
phase insulin secretion was higher 
Family history of DM in whites compared to blacks 
not accounted for (2015.4 +/-180.6vs. 1468.7 +/-
102.8 pmol!liter; P=O.Ol). White 
overweight adolescents also had 
higher lipid levels, more hepatic 
glucose production, and more 
visceral fat than their black 
counterparts- all of which were 
considered to be diabetogenic 
factors. 
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Table 2e. Evidence Table with Quality Review 
Reference # 29 
. . 
Citation Objective Population: Population: Groups Drop outs Selection · .. Measurements Measuremen 
Design Total N Eligibility criteria & comparable? bias t bias 
Setting Duration Demographics potential? potential? 
Source . . . . 
Tershakove To evaluate N-36 Ages: 6-18y YES MODERATE Ht/wt by wall mount LOW 
cAM, body avg = 11.8(+/-0.5) Divided by boys, girls, 5 excluded from & electronic scale. 
Kuppler composition All Obese age AA&W analysis b/c did Time period Averaged the 
KM,et & metabolic 6-18y, Inclusion: AA= 70% female not fast as of recrnitment Tanner stage: by MD value of two 
al.,29 factors & entering >!50% ideal body W = 47% female instructed not given measurements. 
homeostasis CHOP Weight weight; no condition Most differences were Was it over I Body comp: CT 
model Management affecting body not significant after week or scans&DEXA No mention of 
Body assessment of program, composition, lipids, or adjusting for age or several blinding 
composition insulin insulin/glc pubertal status and total mouths? Did Lab values: same & metabolic 
factors in sensitivity homeostasis; parental body fat or BML all patients at place 
obese children (HOMA-IR), consent But ethnic differences least have the 
& adolescents in obese AA in insulin level opportunity to BMI z scores 
and white remained after participate? HOMA-IR 
2003 children& adjusting for total body 
adolescents fat (P~0.03) and subcutaneous CT fat 
(P-0.01) 
Cross-sxual 
Clinic; 
outpatient: 
Philadelphia 
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. 
Potential confounders Confounding Analysis Results: magnitude and Internal validity Exl:ernal Overall quality Comments 
& corrections potential? direction rating validity rating 
. rating 
MODERATE t-test, Insulin & HOMA-IR levels were FAIR FAIR FAIR/POOR Small sample 
Age, BMI, puberty, Mann- significantly associated with fat 
Whitney mass (Spearman r-0.40; P=0.03; May not No age-specific 
All differences were not ANCOVA and r-0.38; P=0.04) and leptin apply to bulk data for 
significant after adjusting for etc (Spearmanr =0.73; P<O.OOOl) of adolescents adolescents only. 
age or pubertal status and total 
body fat or BMI. given mean 
Etlmic group differences in fat mass, age values. Reported 
total CT fat, subcutaneous fat, unadjusted values 
insulin level , leptin level , and but stat that 
higher HOMA-IR were not adjusted values 
significiant after adjusting for age & lead to no 
pubertal status. Differences in significant 
abdominal fut & subcutaneous fat difference 
also independent of total body fat or 
BMI. NO etlmic group differences 
in VAT 
Results essentially contradict other 
studies suggesting racial I etlmic 
differences 
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Table 2f. Evidence Table with Quality Review 
Reference# 30 
. 
.· .· 
.. 
. 
Citation Objective Population: Population: Groups Drop outs Selection Measurements Measure men 
Design Total N Eligibility crHeria & comparable? 
.. 
biaS . t bias 
Setting Duration Demographics potential? . potential? 
Source . . 
Anavian J, To investigate N-309 Ages: 3-18y Divided by age & N/A MODERATE HIGH 
Brenner how often obesity records N=l06 puberty Obese= BMl =:: 95% 
DJ, et al.,30 in childhood is By choosing (CDC) Self-reported associated w/ 1) 3-8yo (n=l5) 
common 5 yrs. Inclusion: presence of BMl 26.6(3.0) only complete 0/W = BMl ::': 85% measures. 
Profiles of metabolic (1993-1998) complete clinical & data charts, (CDC) 
obese abnormalities biochemical may be biased Obese adults= Adult obesity 
such as 2) >8 -12yo 
children hypothyroidism, Obese information for all (n=48) towards the BM1>25 definition is 
presenting hyperlipidemia, children& parameters examined BM131.1 (2.4) type of patient actually 
for hyperglycemia, or adolescents (n= 106); obese by who either Ht/wt & parental standard for 
metabolic hyperinsulinism; referred for definition 3)> 12- 14 (n=l4) makes all obesity= self-report o/w. 
evaluation to detennine endo/ appointments relationship of BM135 (2.4) 
early obesity to metabolic or has Thyroid, lipids, No mention of 
2001 family history & evaluation b/w 4)> 14-19 (n=29) financial insulin, glucose = by blinding of lifestyle 
'93 and '98. BMl 37.8 (2.4) means to go labs cbart 
Cross~sxnal [ nl mean for this thru with all reviewers 
medical record age is -21] testing. 
review 
Specialty clinic IBW also tended 
(PedEnd)@ to increase with 
North Shore age group, but not Hospital; New 
York chol, TG, or HDL. 
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Potential confounders Confounding Analysis Results: magnitude and Internal validity I. External Overall quality Comments 
& corrections potential? direction rating validity rating 
·. 
rating 
No adjustments made in IDGH Descriptive Correlation b/w presence of obesity FAIR/POOR FAIR FAIR/POOR Results section 
statistical analysis stats for in 1 or both parents and higher % of very disappointing: 
each IBW (p=O.Ol): fignre ouly. short, descriptive, 
parameter and incomplete. 
measured. Onset of obesity was at 4.2 +/- 0.9 
years Defined obesity 
!-test & appropriately, but 
Kruskal- Direct relationship b/w age & only reported 
Wallis test abnormal insulin:glucose ratio crude BMI and 
(>1:4). While no one aged 3 to 8 IBW. 
had an abnormal ratio, 34% of those 
aged 14 to 19 did (P<O.Ol). 
The mean index for insulin 
sensitivity was 0.30 in those aged 14 
to 19. A low index indicates more 
insulin resistance. 
"The high percentage ... w/1" or znd 
-degree relatives with [NIDDM] 
(58%) compared w/ a 3-6% 
prevalence ofDM in the US 
population ... suggests that obese 
children represent a segment of the 
population more likely to develop 
DM w/in their lifetime." 
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Table 2g. Evidence Table with Quality Review 
Reference# 27 
Citation Objective Population: Population: Groups Dropouts Selection Measurements Measure men 
Design Total N Eligibility criteria & comparable? bias t bias 
Setting Duration Demographics potential? potential? 
Source . . 
McCance To answer: 1) Are N- 816? Ages: 5-19 5-yr age groups Only 1 incident LOW/MOD DMdxbyWHO MODERATE 
DR, Pettitt metabolic n=816 total or case ofDM No data on criteria for 
DJ, et al.,27 
variables in 
F/u until n=677 w/ a DM parent 1) 5-9y occurred in kid those who epidemiologic Good use of childhood assoc 2) 10-14y 
w/ parental developed DM 3) 15-19y w/o a diabetic dido't agree to studies (see ref) actual parent 
Glucose, diabetes? (2) Does or last biennial Inclusion: participants parent & thus participate exam rather 
insnlin hyperinsulinaemia exam in ongoing wasn't included Serum insnlin & than relying on in childhood & concentrati 
adolescence study(l965); age 5-19 in analysis. (Dx glucose by std labs Family history 
ons& predict diabetes? Pima Iodians w/ NGT at entry into at age 35.2 after by report. 
obesity in (3) Which (Gila River study b/w 1973 & 15.8 yrs of flu) Ht/wt = with light 
childhood variables in Indian 1986; at least 1 clothing & no shoes. Dido't 
children are most and predictive of the Community in subsequent biennial calcnlate BMI 
adolescenc future Arizona) exam; fustiog & 2-h Relative wt used as 
e as development of serum insnlin measured index of obesity. 
predictors diabetes? at baseline; at least Y, Used WHO age-
ofNIDDM Pim, Tohono O'odharn specific std. 
1994 
(Papa go), or both; at 
least 1 parent 3 test variables: 
examined; 1 )2-h plasma glucose 
2 )fasting serum insulin 
3)relative wt 
.... 
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Potential confounders Confounding Analysis Results: magnitude and Internal validity External Overall quaiHy Cornrnents 
& corrections potential? direction rating validity rating 
. 
. 
. rating . . 
MODERATE ANCOVA In each age group, relative weight % FAIR FAIR FAIR Overall aim was to 
Adjusted models for age Kaplan- increased with # of diabetic parents demonstrate 
and sex. Meier (P<O.OOl)~ adjusted for age & sex Applies to association b/w (P<O.OOO!). 
Included only those w/ at Proportiona Pima metabolic variables 
least I diabetic parent I hazards Also a strong positive relationship w/ 2-h populations or & parental DM? 
Multiple plasma glucose(P""0.003) & fasting insulin childrenladole 
Dido't account for models (P=0.003) & fasting glucose (P=0.005). scents w/ at High values of 3 
puberty Of 1120 subjects aged 5-19 y, 9% developed least I test variables did 
DM during a mean 8.4 yrs off/u .. diabetic NOT predict DM 
"In the absence of a high value of relative parent. in those w/o a 
weight, the other metabolic variables are diabetic parent 
poorly predictive ofNIDDM." In other 
words, most Clinical & 
The highest 10-yr incidence (16.3%) applicable to biochemical 
occurred in those w/ values in the upper high-risk characteristics at tertt1e of all 3 variables: fasting insulin, 2-h 
glucose, and relative wt popnlation baseline were 
For 33rd & 66th tertile relative wt: 
stratified by 
Age 10-14 = 110.7% & 137.3% parental DM status 
Age 15·19 = 115.3% & 143.1% 
Adjusted for age & sex. relative wt was most 
predictive ofDM in those age 5·19 w/ 
baseline NGT & at least one diabetic Pt: 
Relative wt: IRR=2.59 (95%CI 1.66· 
4.04;P<O.OO!) 
2·h glucose: IRR=2.41 (95o/oCI 1.26· 
4.59;P~.008) 
Fasting glucose: IRR=1.67 (95o/oCI 1.16~ 
4.04;P~0.005) 
-
53 
Table 2h. Evidence Table with Quality Review 
Reference # 31 
Citation Objective Population: Population: Groups Drop outs Selection Measurements Measuremen 
Design Total N Eligibility criteria & comparable? bias t bias 
Setting Duration Demographics potential? potential? 
Source 
To identify N- ? subjects Ages: 11-17 N/A NR LOW BMI MODERATE 
Pinhas- physical, (26 families) (Meau =14.5 +/- 1.70) Subjective 
HamielO, behavioral, & 
Mean age of pro bands Authors state that Skiufold measures: environmental Skinfold is prone 
Standiford features of N/A n= 42 subjects mean age, wt, sex. to variability 
D, et al.,31 adolescents (aged (11 families) race, duration of Waist & hip circwuf. OM, & incidence based on person 11~17yrs)with All families 11 probauds of parental DM measuring. as is 
The type 2 type 2 diabetes containing au 9 siblings didn't differ b/w Diet intake: circumference. mellitus and their 
family: a adolescent w/ 22? Parents probands who did question- naire Skinfold calipers families to defme 
and didn't maxed out at 
settiog for involvement of T2DM participate. No admio by dietitian 65cm. 
developme known risk factors previously Inclusion: adolescent data shown. 
and to defme a 
nt& profile of at~risk diagnosed at w/ previous dx at this Eating patterns: Diet 
treatment individuals. Children's hospital; both parents Mean age of parents questioned questionnaire probands not 
of Hospital able to participate different that w/ std eating disorder = previously 
adolescent Cross-sxnal Medical (original N=26 families, but entire population questionnaire & validated 
type2 Hospital, Center. 
only 11 families agreed) of adolescents w/ classified by DMS4 against 
diabetes Cincinatti T2DM at this NHANES;but 
mellitus. Contacted by 
hospital. Also Pts probably BMI, sex-ratio, 
letter & %AA under report 
1999 subsequent 
phone call 
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Potential confounders Confounding Analysis Results: magnitude and Internal validity External Overall quality Comments 
& corrections potential? direction rating validity rating 
. rating . ·. 
BMI adjusted for: MODERATE ANOVA "Adolescents w/ T2DM have marked central FAIR FAIR FAIR Inclusion criteria 
Age obesity, poor dietary habits, ... and a did not specify 
Sex Newman- sedentary lifestyle." They also come from Small sample age, and some families who share "many ofthe same high~ 
Race Keuls risk features." size uulikely probands were 
testing to represent > 18, but results 
Anthropometric measurements c/w central all report ouly !bose 
obesity 
adolescents 11-17. 
Participants were obese: mean BMI 37 +/M witb type 2 
11. Mean BMI corrected for age, sex. and DM Report !bat 
race was higher in probands & fathers(>95% probands = >95"' 
in probands & fathers; >85% in mothers & %, but ouly show siblings): 
crndeBMI 
No group differences in fasting numbers. 
concentrations of insulin (P=0.49), proinsulin 
(P~D.41 ), or C peptide (P~0.24) Small sample 
9/11 probands had at least l parent w/ T2DM 
All probands had HbAl C values above 
normal range(0.04..0.08) 
A total of 12/22 parents had or were 
diagnosed w/ T2DM. 
' 
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APPENDIX A CRITICAL APPRAISAL TEMPLATE: HEADERS 
Reference# ___ _ 
Citation Objective 
Design 
Setting 
Population: Population: Groups 
comparable? 
Drop outs 
56 
Total N 
Duration 
Source 
Eligibility criteria & 
Demographics 
Selection 
bias 
potential? 
Measurements MeaSurement 
bias 
potential? 
Appendix B. ELECTRONIC SEARCH STRATEGY 
MEDLINE search for Studies of Adolescent Obesity and Type 2 Diabetes 
Mellitus 
Set Search Terms Reports Found 
#2 Search "Obesity"[MeSH] 67169 
#4 Search ("Ado1escent"[MeSH] OR "Adolescent 
Health Services"[MeSH] OR "Adolescent Nutrition"[MeSH] 
OR "Adolescent Behavior" [MeSH] OR "Adolescent 
Development" [MeSH]) OR "Adolescent Medicine"[MeSH] 110368 
#5 Search #2 AND #4 11203 
#6 Search "Obesity" [MeSH] Field: 
All Fields, Limits: Adolescent: 13-18 years 11203 
#7 Search #5 OR #6 11203 
#9 Search "Diabetes Mellitus, Type 2 [MeSH] 37202 
#10 Search #7 AND #9 65 
# 11 Search #7 AND #9 
Field: All Fields, Limits: English, Humans 403 
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Appendix C. FLOW DIAGRAM : STUDY SELECTION 
·•i····~~fcir~~c~s i~en~iAe<fby 
. ·. literatUre searches 
',<--::· :_ x·.,_-,_-?::<':-} :,··: :·--,----': 
·· >~~:.ioa. ···. 
... 
·•······ :~cle~.inAN~e~··in 
· · Systenutf:ic review. · 
';'-' .:'2 __ ;;_>::::_-/-'::·f·' 
.. ~:k9 
·• ~#~()~~epti~~ c~li<lit 
.• ~~mss;~~o~~~·················• 
•• 2t;et!;?SJ?ecj;ive cohort 
Citations excluded 
N=210 
132 non~relevant topic 
61 nonMUnited States 
13 non-original research 
4 non-adolescent 
Abstracts excluded 
N= 112 
43 non-original research 
33 non-United States 
• 18 non-adolescent 
• 10 non-relevant outcome 
• 4 non-English publication 
4 wrong study design 
No full text available 
N=4 
Full text articles excluded 
N=68 
47 non-original research 
9 non-relevant outcome 
• 7 non-adolescent 
• 4 non-United States 
1 wrong study design 
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Appendix D. AS TRACT LEVEL REVIEW FORM 
ID _____ _ 
Qualifier Yes No Not 
Sure 
Original research (e.g. no editorials)? 
Published io English? 
Participants located io U.S? 
Stndy population ioclndes adolescents? 
Addresses one or more offollowing? 
)> Obesity 
)> Type2DM 
)> Proxy term (s) * 
Stndy Design is one offollowing? 
)> Observational 
)> Systematic review 
)> RCT 
)> Case series or report 
)> Cannot determioe/Other 
Include 
--
Exclude 
--
Background 
--
*Proxy terms: overweight, msulio resistance, glucose mtolerauce, etc ... 
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Appendix E. FULL TEXT LEVEL REVIEW FORM 
ID _____ _ 
Qualifier 
Original research (no review articles, editorials, letters to the editor) 
Published in English? 
Participants located in U.S? 
Study population includes adolescents aged 13~ 18 years? 
Addresses the following key question: 
)> Within the U.S. adolescent population aged 13-18 years, is 
obesity (defmed as B:MI-for-age >95th percentile) associated w/ the 
development of type 2 diabetes mellitus during adolescence? 
Addresses a similar or related question in this population such as: 
)- Is diabetes associated with obesity? 
)> Is obesity associated with precursors or risk factors of diabetes 
(like insulin resistance, glucose intolerance, etc)? 
)- Other relevant research question (explain): 
Study design is one of the following: 
> Observational: Cross-sectional 
> Observational with control group (e.g.: cohort, case-control) 
> Systematic review 
l> RCT 
:> None of the above 
Should the article be excluded for any additional reason? 
> Study reported only in abstract (Full text is not available) 
> Wrong outcome ( i.e. no pharmokinetic/intermediate outcomes) 
> Other? List reason. 
> None of the above- should be included! 
Save as background article? 
Additional comments? 
y N NS 
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Appendix F. CHARACTERISTICS OF EXCLUDED STUDY 
Study 
Jo> Grinstein G, Muzumdar R, et a!., 
Jo> Presentation and 5-year follow-up of type 2 diabetes mellitus in African-
American and Caribbean-Hispanic adolescents. 
);> 2003 
Design 
Jo> Retrospective chart review 
Sample 
Jo> 89 pediatric patients 
Jo> <18 years old 
Jo> type 2 DM diagnosed between 1990 & 2000. 
Outcome Measures 
Jo> BMI 
Jo> Nat'! Diabetes Data Group standards 
Jo> labs 
Results 
J;> Type 2 DM prevalence increased from 12% of new cases in 1990 to 500/o 
in 2000. 
J;> Mean age at diagnosis= 14.0 +/- 2.3 years (range 10-18yrs) 
> Mean BMI at diagnosis was 34.7 +/- 9.0 kg!m2 
Reason for Exclusion 
J;> Data reported in graphs are inconsistent with numbers in text: Figure 1 
data must include patients that would not have met inclusion criteria for 
study (<18 yrs old, no chronic medications, etc); Table 1 numbers exceed 
study population. 
Jo> Chart selection process not detailed. 
J;> Unclear 5-year follow-up period. (For example, a patient diagnosed in 
2000 could not have 5 years offollow-up b/c published in 2003). 
J;> Although retrospective, excluded 20 patients for noncompliance, defined 
as not taking medications on a daily basis. 
J;> Significant change in standard of care occurred during trial: Prior to 1996, 
glipizide 5mg daily was standard of care. After 1996, metformin 500 mg 
twice daily became recommendation 
61 
